Combining Perfluorobutylpentane (F4H5) with Glaucoma Drainage Device Implantation for Silicone Oil-Induced Glaucoma: A Pilot Study.
| Autor: | Kandarakis, Stylianos A., Petrou, Petros, Doumazos, Spyridon, Chronopoulou, Konstantina, Doumazos, Leonidas, Halkiadakis, Ioannis, Georgalas, Ilias |
|---|---|
| Předmět: |
GLAUCOMA surgery
PROSTHETICS SILICONES PILOT projects ENDOTHELIAL cells PREOPERATIVE care GLAUCOMA INTRAOCULAR pressure CLINICAL trials CYTOMETRY ARTIFICIAL implants SURGERY PATIENTS POSTOPERATIVE care FLUOROCARBONS TREATMENT effectiveness PRE-tests & post-tests DRUGS DESCRIPTIVE statistics MEDICAL drainage FOREIGN bodies in eyes COMBINED modality therapy DRUG utilization CUTANEOUS therapeutics PATIENT safety GLAUCOMA treatment MEDICAL needs assessment EVALUATION THERAPEUTICS |
| Zdroj: | Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi; Oct2023, Vol. 53 Issue 5, p281-288, 8p |
| Abstrakt: | Objectives: Our aim was to perform a perfluorobutylpentane (F4H5) washout in conjunction with glaucoma drainage device (GDD) placement in patients with silicone oil (SO)-induced glaucoma. In this report we present our preliminary results concerning the effectiveness in clearing the SO and the safety of the procedure. Materials and Methods: Eight patients who previously underwent pars plana vitrectomy with SO tamponade due to retinal detachment were selected. Removal of SO was performed on average 10 months after initial surgery. All patients developed glaucoma with evidence of SO remnants in the anterior chamber (AC) and angle. Removal of the remaining SO with F4H5 washout was performed in all cases with concomitant insertion of a GDD to treat the refractory glaucoma. Intraocular pressure (IOP), SO remnants, endothelial cell count, and need for glaucoma medications were evaluated up to 12 months after the surgical procedure. Results: All patients had uneventful surgery with no major complications 12 months postoperatively. A marked reduction of SO remnants in the AC and angle was observed in all cases after surgery. There was a 60.9% decrease in mean IOP 12 months postoperatively (p<0.05) and the need for glaucoma medication was lower in all patients (mean topical medicines: 4 preoperatively vs. 0.75±0.89 postoperatively; p<0.05). Endothelial cell density showed no significant change (mean 2012±129 cells/mm2 preoperatively vs. 1985±134 cells/mm² postoperatively; p>0.05), and there were no signs of corneal edema. Conclusion: F4H5 is an effective emulsifier for removing SO remnants and may be safely used in conjunction with GDD placement in order to control IOP in eyes with silicone oil-induced glaucoma. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|